Healthcare Industry News: HSMN NewsFeed
News Release - April 8, 2019
LifeScan Names Brian Heald as its New Head of ProductFormer Roche, Glutalor executive will help usher in a new era of innovation, growth, and expansion for the newly independent blood glucose monitoring company
CHESTERBROOK, Pa., April 8, 2019 -- (Healthcare Sales & Marketing Network) -- LifeScan announced today that it has named diabetes-device veteran Brian Heald as its new Head of Product effective immediately. Heald brings more than 25 years of product development success to LifeScan, a world leader in blood glucose monitoring and maker of the iconic OneTouch® brand, which has 20 million patients worldwide.
Most recently, Heald was Chief Executive Officer of Glutalor Medical, which manufacturers and markets advanced continuous glucose monitoring (CGM) technology. He has spent much of his career in senior leadership roles at Roche Diabetes Care as SVP Head of Global Research & Development and Board Director, SVP Head of Operations & Development for North America.
"We are thrilled to have someone with Brian's accomplishments join us at this exciting new time of LifeScan's history," says Val Asbury, President and CEO of LifeScan. "As we look to grow and expand in diabetes and chronic disease management, Brian knows the diabetes device space as well as anyone and also knows how to innovate and challenge the status quo. We are excited for our future with Brian as a member of the team."
As Head of Product, Heald will lead all aspects of product development including R&D, digital development, regulatory, clinical, and partnerships as well as The LifeScan Institute. He will also manage product and service development with LifeScan's current and future strategic partners, such as Welldoc, creator of the award-winning digital therapeutic BlueStar®, which powers OneTouch Reveal® Plus and is the first digital therapeutic approved by the FDA for adults with type 2 diabetes. "I am looking forward to working with a company that has LifeScan's legacy of patient care and quality products," Heald says. "Combine that esteemed history with its future growth opportunities and our potential to serve even more people around the world is limitless."
With a vision to create a world without limits for people with diabetes, LifeScan is a world leader in blood glucose monitoring – globally more than 20 million people depend on OneTouch brand products to help them manage their diabetes. For over 35 years, LifeScan has had an unwavering commitment to improving the quality of life for people with diabetes by developing products defined by simplicity, accuracy, and trust. For more information, visit www.LifeScan.com and www.OneTouch.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.